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Abstract  Psychosomatic  disorders  are  among  the  most  common  psychiatric  disorders  in  gen-
eral practice,  with  a  prevalence  of  16%.  These  patients  often  turn  to  different  general
practitioners  and/or  non-psychiatric  specialists  for  long  periods  of  time  and  represent  a  diag-
nostic and  therapeutic  challenge,  as  the  possible  organic  component  makes  it  complex  and
difﬁcult to  manage.
The  reported  case  is  a  24-year-old  male  patient  with  a  diagnosis  of  Somatic  Symptoms  Disorder
and multiple  psychiatric  comorbidities.  The  purpose  of  this  study  is  to  review  the  reconceptu-
alization of  Somatoform  Disorders’  DSM-5  diagnosis,  which  can  be  useful  for  psychiatrists  and
non-psychiatric  physicians  for  the  approach  and  management  of  these  patients.











sychosomatic  disorders  are  among  the  most  common  psy-
hiatric  disorders  in  general  practice,  with  a  prevalence
f  16%.1--3,5 Before  going  to  a  psychiatrist,  these  patients
sually  see  general  physicians  and/or  non-psychiatric  spe-
ialists  for  long  periods  of  time2,4,6 which  is  enabled  by  these
atients’  resistance  to  acknowledging  that  their  physical
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nd  not  only  an  organic  origin,  resulting  in  multiple  thera-
eutic  managements  and  chronic  use  of  health  services.2,4,5,8
Moreover,  the  important  association  of  psychiatric
omorbidity  (depression,  anxiety  and  psychopathology  of
haracter),  as  well  as  medical  illnesses,1,2,4,6,7 makes  them  a
iagnostic  and  treatment  challenge  not  only  for  the  psychia-
rist,  but  also  for  general  practitioners  and  other  specialties,
ince  the  possible  organic  component  makes  them  complex
nd  difﬁcult  to  manage.4,7
Regarding  its  evolution,  chronicity,  social  and  interper-
onal  dysfunction,  difﬁculties  at  work  and  the  frequent
se  of  medical  services  are  the  common  characteristics
f  these  disorders,  which  lead  to  an  elevated  level  of
issatisfaction  in  both  the  doctor  and  the  patient.5,7,8




















pDiagnostic  reconceptualization  in  DSM-V  on  somatoform  diso
The  present  article  presents  the  case  of  a  patient  who  exem-
pliﬁes  this  pathology.
Case presentation and discussion
The  patient  is  a  24-year-old  male,  from  Monterrey,  Mexico.
He  is  single,  works  at  a  ﬂea  market,  with  an  upper  secondary
level  of  completed  education  and  a  low  socioeconomic  sta-
tus.  He  had  a  background  of  excellent  school  performance
with  academic  scholarship  through  secondary  school  and
high  school.  Prior  to  the  onset  of  the  psychopathology,  there
was  adequate  and  constant  work  activity,  as  well  as  more
social,  recreational  and  interpersonal  involvement.  During
his  childhood,  he  refers  to  being  sexually  abused  (improper
touching)  on  two  occasions  and  describes  a  stressing  family
environment  with  constant  verbal  and  psychological  abuse
toward  him  and  other  family  members.  This  prolongs  until
adolescence.  Subsequent  to  his  parents’  separation,  he
maintains  a  scarce,  almost  null,  relationship  with  his  father,
which  stands  as  an  event  which  impacts  his  childhood  and
personal  development  in  a  negative  way.He  has  attended  the  Psychiatric  Outpatient  Clinic  volun-
tarily  on  July  2012  after  presenting  depressive  symptoms
for  more  than  6  months,  secondary  to  pollakiuria  with





Table  1  Medical  history  in  relation  to  the  urinary  symptom.
Date  Diagnostic  studies  
March  2009  EGO  --  normal
Pelvis  and  kidney  Eco  --  normal
March 2009  Prostatic  Ag.  --  normal
EGO  --  normal
Urine  culture  --  Enterococcus  Sp.
May 2009  Spermculture:  Klebsiella  Sp.  
June 2009  Spermculture  --  S.  aureus
Klebsiella
July 2009 Retrograde  urethrography:  narrowness  of  the
prostatic  urethra.  Checked  with  US  ﬁnding  the
prostate  to  have  normal  dimensions  and
caliber.  Complete  emptying  of  urine.
December  2009  Spermculture  --  S.  aureus  
January 2010  Spermculture  --  S.  aureus  +  Proteus  vulgaris
Urine  culture  --  negative
EGO  --  normal
February 2010  No  studies  prescribed  (review  of  previous).  
June 2010  No  studies  prescribed.  
November  2010  Excretory  urography:  normal  
December 2010  Urodynamic  study  prescribed:  not  performed
due to  lack  of  economic  resources.
January 2011  Refer  nondiagnostic  ureterocele  
May 2012  Urine  smear  --  negative
Urine  culture  --  Enterobacter  cloacae
EGO  -  normal
Prostatic  US  --  normals  103
eath,  presenting  20--25  urinations  a  day,  with  intervals
f  10--20  min  in-between  and  without  disrupting  sleeping
ours.  He  denies  pain  while  urinating,  pushing,  tenesmus,
ever  or  any  other  added  symptoms.  Over  4  years  the
atient  saw  multiple  doctors  and  different  urologists,  who
equested  para-clinical  studies,  with  different  non-certain
iagnoses  and  diverse  pharmacological  treatments  without
mprovements  in  the  urinary  symptom.  (Table  1)
At  ﬁrst,  in  view  of  the  diagnostic  doubt  and  lack  of
esponse  to  treatments,  the  patient  thought  that  the  ori-
in  of  the  symptom  was  caused  by  a  physical  illness;  then,
e  associated  it  with  the  unresolved  mourning  of  his  father’s
eath  which  concurs  with  the  onset  of  the  symptoms.
Secondary  to  the  onset  of  the  urinary  symptom,  the
atient  interrupts  his  personal  and  professional  growth:
uits  his  job,  stops  frequenting  his  friends  and  remains  iso-
ated  at  home  for  over  2  years,  focusing  his  life  on  attending
pecialists  and  trying  to  solve  his  symptoms.  Two  years  later,
he  patient  reduces  the  frequency  of  urination,  accomplish-
ng  a  urination  rate  of  once  every  2  h,  and  begins  working
art-time.  However,  the  sense  of  urgency  to  urinate  as  well
s  the  constant  preoccupation  of  not  being  able  to  reach  a
lace  to  urinate,  lead  to  a  poor  working  growth  and  avoid-
nce  of  interpersonal  relationships  with  limited  social  and
ecreational  activities.
Diagnosis  Treatment
Not  speciﬁed  Not  speciﬁed

















Likely  left  ureterocele  Recommends  surgery
Not  speciﬁed  Diazepam
Prostatitis  Solifenacin



































































































Six  months  prior  to  attending  psychiatric  consultation
e  begins  to  feel  sadness  every  day  for  almost  the  entire
ay;  this  sadness  is  linked  to  his  urinary  problem  and  his
ifﬁculties  in  accomplishing  things  in  his  personal  life  and
t  work.  He  refers  to  feeling  ‘‘handicapped’’,  saying  he
elt  ‘‘like  trash’’,  occasional  crying,  anhedonia  and  melan-
holy.  A  month  ago  he  began  to  present  terminal  insomnia,
eduction  of  appetite,  weakness  and  occasional  feelings  of
opelessness,  causing  signiﬁcant  discomfort  which  inter-
eres  with  his  performance  in  his  everyday  activities.  He
enies  having  thoughts  of  death,  or  suicidal  thinking  and/or
lanning.
Previous  to  the  pollakiuria,  a  pattern  of  preoccupation
bout  trivial  situations  with  a  tendency  for  the  catastrophic
s  noticed,  which  causes  a  persistent  and  general  anxiety
ot  limited  to  a  speciﬁc  situation  and  is  manifested  by  con-
tant  hand  sweating,  palpitations,  mild  tremors,  occasional
rritability,  fatigue  and  difﬁculty  focusing.  The  anxiety  symp-
oms  ﬂuctuate,  but  have  a  long  evolution,  which  has  been
xacerbated  over  the  last  6  months.
tructural exam
he  patient  manifests  evasive  and  dependent  behavior,
hich  has  had  him  working  for  the  last  2  years  at  a  place
hich  does  not  represent  a  signiﬁcant  challenge  nor  does  it
emand  formal  obligations,  hiding  behind  his  urinary  prob-
em  to  avoid  looking  for  a  stable  job,  with  a  dependent
nd  victimized  line.  The  evasive  behavior  is  also  manifested
y  his  disproportional  fear  when  facing  everyday  situations,
enerating  anguish  and  resulting  in  deterioration  of  work
nd  interpersonal  relations.
He  presents  a  predominately  devaluated  self-concept,
escribing  himself  as  scared,  insecure  and  feeling  that  he
as  little  value;  this  interferes  with  his  interpersonal  rela-
ionships  with  others.  He  displayed  defense  mechanisms,
ainly  repressive,  like  rationalization,  constantly  using  his
rinary  symptom  as  an  excuse  to  justify  his  evasive  and
ependent  traits;  affective  isolation  when  describing  his
ather’s  death  as  an  event  that  caused  little  pain  and  dis-
lacing,  redirecting  that  pain  toward  his  urinary  symptom.
Despite  his  difﬁculty  to  relate  to  others,  he  manifests
n  ability  to  empathize  with  others  and  an  ability  to  be
rateful,  expressing  gratitude  for  the  time  dedicated  to  his
valuation.  Regarding  his  aggressive  impulses’  control,  he
oes  not  present  frequent  situations  which  put  him  in  con-
ict,  thus  making  his  ability  to  contain  and  repress  emotions
vident.  However,  on  a  few  occasions  we  were  able  to  see
he  inﬁltration  of  primary  process  thinking,  causing  him  to
ake  impulsive  decisions,  later  realizing  this  through  his
bility  for  self-reﬂexive  thinking.
In  respect  to  the  quality  of  his  interpersonal  relation-
hips,  he  is  unable  to  establish  long  lasting  friendships
r  romantic  relationships  and  maintains  a  superﬁcial  and
ot  very  affective  relationship  with  his  family  members.
egarding  his  tolerance  of  anxiety,  we  can  observe  a  peren-
ially  apprehensive  tendency  and  a  tendency  to  exaggerate
atastrophes,  which  is  expressed  through  his  urinary  fre-
uency  and  in  everyday  situations,  like  sweaty  palms  when
nteracting  with  people,  and  in  his  sex  life,  presenting  antic-
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Despite  observing  in  the  patient  the  cognitive  ability  and
esire  to  develop  the  personal  and  professional  aspects  of
is  life,  he  does  not  perform  any  type  of  activities  where  he
xperiences  pleasure  and  satisfaction.
The  patient  has  self-reﬂexive  ability  to  suggest  that  pol-
akiuria  is  the  superﬁcial  symptom  covering  deeper  problems
elated  to  self-esteem  and  his  character.
SM-V diagnosis
00.82.  Somatic  Symptom  Disorder.
300.02.  Generalized  Anxiety  Disorder.
296.21  Major  Depressive  Disorder.
3001.9  Unspeciﬁed  Personality  Disorder.
iagnostic analysis
he  DSM-V  modiﬁes  the  Somatomorphic  Disorders  and  cre-
tes  a  new  diagnostic  entity  in  its  place;  Somatic  Symptoms
isorder  (SSD)  and  related  disorders.  Evidence  of  multiple
ab  and  imaging  studies  without  signiﬁcant  pathological  ﬁnd-
ngs,  which  explain  the  severity  of  the  symptoms,  along  with
he  lack  of  response  to  several  medical  treatments  given
y  different  urologists,  ruled  out  the  presence  of  a  known
edical  condition  that  could  explain  the  patient’s  urinary
ymptom,  thus  concluding,  according  to  the  DSM-V,  the  pres-
nce  of  a  SDD  (Table  2).8
The  urinary  symptom  generated  discomfort  and  major
nxiety  which  impacted  the  different  areas  of  the  patient’s
ife  in  a  negative  way,  since  the  constant  feeling  of  inability
indered  his  development  in  his  work,  social  and  personal
ife  (Criterion  A).  The  symptom  became  the  center  of  his
ife,  and  he  devoted  excessive  time  and  energy  worrying
bout  his  health  and  searching  for  an  effective  treatment
or  over  4  years  (Criteria  B  and  C).  The  sudden  onset,  with  a
ersistent  course  and  long  evolution  of  a  single  very  severe
omatic  symptom,  producing  marked  anxiety  and  disability
n  his  everyday  life,  speciﬁes  the  diagnosis  as  Severe  Persis-
ent  Somatic  Symptoms  Disorder.
The  new  components  of  somatic  symptoms  disorders  are
ncorporated  in  this  new  edition  of  the  DSM-V:  affection,
ognition  and  behavior  within  SSD  criteria,  providing  a  more
ccurate  and  more  comprehensive  vision  of  the  patients’
eal  signs  and  symptoms,  in  comparison  to  the  DSM-IV,  which
valuates  only  somatic  symptoms  (1  or  more).  This  diagnos-
ic  reconceptualization  provides  a  useful  tool  for  primary
are  doctors  or  any  other  non-psychiatrist  specialist.  This
ould  be  very  beneﬁcial  in  order  to  reach  a  proper  diagnosis
nd  treatment  in  an  earlier  manner,  improving  the  prognosis
nd  avoiding  economic  expenses  in  healthcare.6,7,9,10
Additionally,  the  criteria  for  a  major  depressive  disorder,
ith  a  moderate  single  episode,  are  met,  clinically  evident
nd  verbally  expressed  by  the  patient.
Regarding  anxiety  symptoms,  these  were  reported  before
he  onset  of  the  urinary  symptom,  with  exacerbation  in
he  last  6  months,  causing  signiﬁcant  discomfort.  The  non-
peciﬁed  personality  disorder  is  justiﬁed  by  presenting
vasive  traits  manifested  in  social  inhibition,  feelings
f  inability,  hypersensitivity  to  negative  evaluation  and
voidance  of  activities  which  require  signiﬁcant  interper-
onal  contact,  causing  clinically  signiﬁcant  dysfunction  and
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Table  2  Diagnostic  criteria  for  Somatic  Symptoms  Disorder  DSM-V.
Somatic  Symptoms  Disorder
A.  One  or  more  somatic  symptoms  that  cause  discomfort  or  lead  to  signiﬁcant  problems  in  everyday  life.
B. Excessive  thoughts,  feelings,  or  behaviors  related  to  the  somatic  symptoms  or  associated  with  preoccupation  over
health as  is  manifested  by  one  or  more  of  the  following  characteristics:
1. Disproportionate  and  persistent  thoughts  about  the  severity  of  the  patient’s  own  symptoms.
2. Persistently  elevated  degree  of  anxiety  about  the  patient’s  health  or  symptoms.
3. Excessive  time  and  energy  dedicated  to  these  symptoms  or  to  worrying  about  health.
Although a  somatic  symptom  may  not  be  continually  present,  the  symptomatic  disorder  is  persistent  (generally  more  than
six months).
Specify  if:
Predominance  of  pain  (before  painful  condition):  this  speciﬁer  applies  to  individuals  whose  somatic  symptoms  imply
pain over  all.
Specify  if:
Persistent:  A  persistent  course  is  characterized  by  the  presence  of  intense  symptoms,  important  alteration  and
prolonged duration  (more  than  six  months).
Specify  the  actual  severity:
Light:  Only  matches  one  of  the  symptoms  speciﬁed  in  criterion  B.
Moderate:  Matches  2  or  more  of  the  symptoms  speciﬁed  in  criterion  B.





























s(or one  very  intense  somatic  symptom).
discomfort  in  social,  work  and  interpersonal  areas.  We  can
also  observe  dependent  personality  traits  with  the  patient’s
difﬁculty  to  make  decisions  and  not  assuming  responsibility
according  to  his  age  and  stage  in  life.
Therapeutic plan
When  SSDs  coexist  with  a  mood  or  anxiety  disorder,  the
administration  of  psychiatric  medications  is  indicated,  along
with  a  psychotherapeutic  treatment.  Therefore,  we  decided
to  follow  a  combined  treatment.2,5,12--14
Pharmacological treatment
The  pharmacological  treatment  approach  to  SSDs  has  been
complicated  due  to  the  lack  of  conceptual  clarity  and  exces-
sive  emphasis  on  the  psychosocial  causation  and  efﬁcacy
of  psychological  treatments.15 Every  type  of  psychiatric
medication  is  used  in  clinical  practice  to  treat  SSDs,  and
there  are  systemic  studies  focused  on  ﬁve  main  medication
groups:  tricyclic  antidepressants  (TCAs),  inhibitors  of  sero-
tonin  reuptake  (SRI),  serotonin  and  noradrenaline  reuptake
inhibitors  (SNRIs),  atypical  antipsychotics,  and  herbal-based
medications.12,15 Evidence  shows  that  these  ﬁve  groups  are
effective  for  a  wide  variety  of  disorders  and  that  all  types
of  antidepressants  seem  to  have  certain  degree  of  effective-
ness  on  SDDs  and  related  disorders.12,13,15 TCAs  and  SRIs  are
the  most  utilized  pharmacological  agents  in  SSDs.  Neverthe-
less,  there  are  little  data  supporting  its  effectiveness  as  a
stand-alone  treatment.2,5,12,13
The  research  leaves  many  unanswered  questions  about
dosage,  treatment  duration,  improvement  sustainability  in
the  long  run  and  variability  in  responses  to  different  types
of  medications.15 According  to  Carlat  (2012)  the  evidence  of
somatic  treatment  of  depression  in  adults  reports  sertraline
i
p
so  be  a  ﬁrst-choice  antidepressant  that  is  hard  to  top,  given
ts  combination  of  efﬁcacy,  tolerability  and  low  cost.16
In  the  reported  case,  50  mg  of  sertraline/day  is  pre-
cribed,  along  with  long-acting  benzodiazepine  (clonazepam
.5  mg)  at  night  due  to  the  presence  of  comorbidity
ith  depression  and  anxiety.  The  depression  symptoms  are
esolved  within  2  months;  however,  doctors  decided  to  dou-
le  the  sertraline  dosage  (100  mg)  at  6  weeks  and  triple  it
150  mg)  at  3  months  due  to  the  persistence  of  the  anxiety
ymptom.  The  urinary  symptom  occurs  with  less  frequency
ntil  it  is  fully  resolved  after  6  months  of  combined  treat-
ent.  Clonazepam  is  suspended  after  4  months  due  to  a  good
esponse  to  the  antidepressant  and  to  avoid  dependence  on
he  medication.  Because  of  the  signiﬁcant  improvement  in
he  urinary  symptom  as  well  as  the  depressive  and  anxiety
ymptoms,  SRI  is  gradually  reduced  to  50  mg/day  until  its
ull  suspension  2  years  later.  The  patient  tolerates  the  med-
cation  adequately  without  any  report  of  signiﬁcant  adverse
ide  effects.
sychotherapeutic treatment
rom  the  non-pharmacologic  treatment,  cognitive  behav-
oral  therapy  (CBT)  proved  to  be  the  most  effective;
owever,  these  interventions  have  not  been  proven  efﬁcient
n  the  long  run.5,12,13 According  to  Kaplan  and  Sadock,  in
oth  the  individual  and  group  psychotherapy  ﬁelds,  the  idea
s  to  help  patients  face  their  somatic  symptoms,  express
ubjacent  emotions  and  develop  alternative  strategies  to
xpress  their  feelings.  Additionally,  some  results  indicate
hat  psychodynamic  psychotherapy  is  beneﬁcial  to  psycho-
omatic  patients,  where  the  therapeutic  alliance  plays  an
mportant  role  and  is  solidiﬁed  through  empathy  with  the
atient’s  suffering.17
Doctors  are  not  recommended  to  face  patients  who

















































































nstead,  they  must  recognize  the  reality  of  the  physical  ail-
ents,  even  if  they  understand  that  their  origin  is  basically
ntrapsychic.2,4,5 An  easy  route  of  entry  into  the  emotional
spects  of  physical  suffering  is  the  examination  of  its  inter-
ersonal  ramiﬁcations  in  the  patient’s  life.7,17
We  decided  to  begin  with  individual,  expressive  psycho-
ynamic  psychotherapy,  with  a  focus  on  object  relations,
wice  a  week,  in  45--50-min  sessions.  During  the  ﬁrst
 months  they  included  behavioral  techniques  focused
n  the  urinary  symptom.  These  techniques  consisted  of:
mptying  the  bladder  every  2  h,  going  to  the  bathroom
nly  to  wash  his  hands  and/or  face  and  performing  jaw
xercises.
In  parallel  to  the  pharmacological  treatment,  the  patient
ommits  to  psychotherapeutic  treatment,  with  results  which
mpacted  his  life  in  a  positive  way;  he  enrolls  in  univer-
ity,  takes  responsibility  for  his  school  expenses  and  his
reatment  and  gradually  becomes  involved  in  social  and
ecreational  activities.  The  patient  continues  with  psycho-
ynamic  psychotherapy  to  keep  working  on  his  evasive  and
ependent  personality  traits,  which  contributed  to  the  onset
f  the  physical  symptom  and  the  subsequent  personal  and
rofessional  deterioration.
herapeutic plan analysis
he  combination  of  treatments  (pharmacological/
sychotherapeutic)  can  be  necessary  in  patients  with
evere  SSD  of  a  long  evolution  as  in  the  case  presented,
ven  more  when  there  is  a  comorbidity  with  depression
nd/or  anxiety.  Consequently,  despite  the  fact  that  there
s  no  compelling  evidence  for  the  effectiveness  of  antide-
ressants  in  SSDs,  the  choice  was  based  on  tolerability,
herapeutic  efﬁciency  in  depression  and  anxiety  and  low
ost,  given  the  patient’s  economic  problems.
Despite  the  psychotherapeutic  treatment  of  choice  of
SDs  being  CBT,  above  the  pharmacological  treatment  by
tself  or  any  other  type  of  psychotherapy,  these  types  of
nterventions  have  not  been  proven  to  be  effective  in  the
ong  run,  since  most  clinical  trials  only  evaluate  results  in
he  short-term.  In  this  case,  the  patient  attends  the  psy-
hiatric  outpatient  clinic  with  the  idea  and  hope  that  his
hysical  symptom  may  have  a  psychological  cause;  as  well
s  a  great  motivation  to  improve  his  personality  aspects
hich  prevented  him  from  relating  to  others.  Therefore,
t  is  decided  in  conjunction  with  the  patient  to  begin  a
ong-term  psychodynamic  psychotherapy  process  comple-
ented  with  behavioral  techniques.  The  success  of  the
reatment  obtained  thus  far  seems  favored  by  a  good  ther-
peutic  alliance,  self-reﬂective  ability  and  commitment  to
he  treatment.
onclusions
he  common  characteristic  evolution  of  chronicity,  social
ysfunction,  work  difﬁculties  and  frequent  use  of  medical
ervices  lead  to  a  level  of  dissatisfaction  and  frustration  on
he  patient  as  well  as  the  doctor,  as  well  as  a  high  economic
ost  in  healthcare  services.2,4,5,18
One  of  the  most  valuable  contributions  in  the  re-
onceptualization  of  the  DSM-V  for  somatic  disorders  isD.  Ibarra-Patrón  et  al.
hat  it  obliges  all  non-psychiatric  colleagues  in  the  mental
ealth  area  to  place  stress,  not  on  the  description  of  the
ymptom  per  se,  but  in  exploring  how  the  symptom  affects
he  patient:  (a)  emotionally  (i.e.  makes  him  depressed,
nguished,  irritated,  etc.);  (b)  cognitively  (i.e.  rumination
n  the  symptom,  catastrophic  ideas,  etc.);  and  (c)  behav-
orally  (i.e.  constant  medical  consultations,  stop  working,
tc.).8
Even  though  the  chief  complaint  was  pollakiuria,  by
nderstanding  how  it  affected  the  patient,  not  only  phys-
cally,  but  also  in  other  aspects  of  his  life  and  his
urroundings,  it  helped  us  situate  the  functioning  of  the
ymptom  in  his  life,  to  have  a  more  realistic  idea  of  the
atient’s  ailment  and  to  have  a  more  empathic  treatment
oward  him.  This  more  integral  approach  allowed  the  cre-
tion  of  a  treatment  plan  which  included  not  only  the
ymptom,  but  other  aspects  of  the  patient’s  life  which  were
ubjacent  to  the  physical  symptom.
The  DSM-V  modiﬁcations  in  SSD  diagnostic  criteria  lead  all
ealthcare  professionals  toward  a  more  integral  evaluation
nd  approach,  which  may  help  doctors  to  have  a  more  realis-
ic  comprehension  of  the  patient,  thus  avoiding  improper  or
ncomplete  diagnosis  and/or  management,  which  only  favors
hronicity  and  worsens  prognosis.6,7,9--11,18
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